Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease. - Wikidata - awgldk - TriplyDB

Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.

Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.

http://www.wikidata.org/entity/Q40122523

about

Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans.Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease.miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes MicroRNA-155 promotes the pathogenesis of experimental colitis by repressing SHIP-1 expression MicroRNAs: how many in inflammatory bowel disease?Assessment of disease activity in pediatric ulcerative colitis.Functional annotation of structural ncRNAs within enhancer RNAs in the human genome: implications for human disease.MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials.MicroRNA-146a Overexpression Impairs the Positive Selection during T Cell Development.Unravelling the molecular basis for regulatory T-cell plasticity and loss of function in disease.

P2860

Q33746984-C5C25641-9CD1-4579-9760-9F7B338C5489 Q36088921-E6CF8630-7BEB-4A19-923B-4D2704AFA0DB Q36310864-0935B79F-B25B-4DCF-BB68-159F4B3A1724 Q37644020-8CA96639-83CD-4B43-BCE9-D6C32D6AEAF7 Q38823581-8E9E9482-A120-4A02-A077-606070D11143 Q38825374-8C788874-BF61-439F-A71F-C3F2C371F811 Q46261346-794BBBAB-FFC0-4DD0-93D9-D38197D9DEC2 Q47386784-35089087-858C-4C31-A3E9-33A48586122E Q50147500-1D6C4507-9FEA-4874-A4B2-C2D203BC7557 Q52677986-9CF14D2C-856B-4B0B-B399-6720231D1A76

P2860

Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.

http://www.wikidata.org/entity/Q40122523

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Role of Altered Expression of ...... th Inflammatory Bowel Disease.

@en

type

label

Role of Altered Expression of ...... th Inflammatory Bowel Disease.

@en

prefLabel

Role of Altered Expression of ...... th Inflammatory Bowel Disease.

@en

P1433

Q40122523-399155A9-0255-4509-841A-EC69995E4728

P1476

Q40122523-D93424AA-AFB1-4DDC-9ECC-35C5CC2705BF

P2093

Q40122523-2F8A5927-1FC1-488D-A8DA-0D47D5134CA7

Q40122523-3A41B33E-0572-4FD5-B6BA-08D182DA9C2E

Q40122523-48045F5E-83A1-4304-9EAD-9CECBAE26B4A

Q40122523-625DF36F-FC11-48E3-BC90-6E7344665791

Q40122523-78C39489-5DD6-45EF-944B-3C12321F73A0

Q40122523-89FED9EE-BA51-4EAD-921E-690A12F188F6

Q40122523-905C4EC7-BD39-4389-BC2D-1760397AF598

Q40122523-999141A4-C18F-4747-99BE-E967989BA555

Q40122523-B4F2E633-8AE6-4859-9B8C-88C5FC374B3A

Q40122523-C1E7E7EB-0D8F-4900-BF79-42222F879757

P2860

Q40122523-04E896D7-6344-4D45-948A-A3BE193D9318

Q40122523-0B02D2E9-1D12-4A39-96F0-36864A5FD6DB

Q40122523-0B5663E7-6609-47E2-BCD4-37121EC4F410

Q40122523-0C403BF6-0646-4E1A-B110-67403D44387A

Q40122523-12200B3B-EFC6-47DF-849D-B54D26385CDD

Q40122523-1913EF93-7740-479D-953F-383980F1327C

Q40122523-1C6515F5-3E55-4A4B-AAEB-1413506EAF85

Q40122523-20B2794E-DA58-4235-B40D-98E2EC5DE3F3

Q40122523-25EA1F45-9C08-4065-9A64-7EB4C08781E1

Q40122523-2D3AA388-70FF-47B9-A681-A1852D2D070D

P304

Q40122523-29D43232-DAA2-42D8-9909-6AC8B52BF4E2

P31

Q40122523-BAC796AC-3FE3-496A-95DA-F192DFCF1435

P356

Q40122523-FF7BF913-0D8B-470F-89EC-3EE8ACF87329

P433

Q40122523-EE4D120D-F4C7-4878-9601-252F989087F8

P478

Q40122523-EEB3FD2B-DCE2-4778-9024-80B0F0B48D94

P50

Q40122523-8EA76FEC-CBEB-4C72-8D8E-F58DC1405527

P577

Q40122523-AFC43D86-4414-42EC-811B-57CD3BDE60DE

P698

Q40122523-5052C181-AAB2-4ED8-9F1C-70D784924D04

P921

Q40122523-4C2AC817-9C12-4331-A5FE-DC151E3580D1

P356

MIB.0000000000000687

P1433

Inflammatory Bowel Diseases

P1476

Role of Altered Expression of ...... ith Inflammatory Bowel Disease

@en

P2093

András Kiss

http://www.w3.org/2001/XMLSchema#string

Attila J Szabó

http://www.w3.org/2001/XMLSchema#string

Dolóresz Szabó

http://www.w3.org/2001/XMLSchema#string

Dorottya Kocsis

http://www.w3.org/2001/XMLSchema#string

Dániel Szűcs

http://www.w3.org/2001/XMLSchema#string

Erna Sziksz

http://www.w3.org/2001/XMLSchema#string

Gábor Lendvai

http://www.w3.org/2001/XMLSchema#string

Gábor Veres

http://www.w3.org/2001/XMLSchema#string

Katalin E Müller

http://www.w3.org/2001/XMLSchema#string

Nóra J Béres

http://www.w3.org/2001/XMLSchema#string

P2860

Cytoscape: a software environment for integrated models of biomolecular interaction networks

miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice

B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1

Gene Ontology Consortium: going forward

Expression of microRNA-122 contributes to apoptosis in H9C2 myocytes.

MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia

Inflammatory bowel disease in pediatric and adolescent patients.

P304

327-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MIB.0000000000000687

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26752469

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases